Novartis Ag (NVS) FCF Margin (2009 - 2026)
Novartis Ag (NVS) posted FCF Margin of 38.60% for Q2 2026, down 6.47 percentage points from 45.06% a year earlier but up 7.92 percentage points from the prior quarter.
Powered by 
Analysis
Novartis Ag (NVS) FCF Margin (2009 - 2026) Analysis & Trends
For the trailing twelve months through Jun 30, 2026, FCF Margin at Novartis Ag was 35.39%, down 5.15 percentage points year-over-year; for FY2025, it came in at 32.27%, down 0.03 percentage points from FY2024.
- Annual FCF Margin shows a five-year change of +6.84 percentage points (FY2020 to FY2025).
- In prior years, Novartis Ag's FCF Margin was 32.30% in FY2024 (+2.82 pp), 29.49% in FY2023 (-2.07 pp), 31.56% in FY2022 (-1.18 pp) and 32.74% in FY2021 (+7.30 pp).
- Quarterly FCF Margin has run from a low of 15.21% in Q1 2022 to a high of 51.52% in Q3 2024 over five years.
- On a year-over-year basis, FCF Margin increased in five of the last eight quarters, with an average year-over-year change of +1.12 percentage points.
- The strongest year-over-year quarter for FCF Margin in the past five years was Q1 2023, with a gain of 13.73 percentage points; the weakest was Q4 2023, with a drop of 15.91 percentage points.
- According to Business Quant data, FCF Margin for the three prior quarters was 30.67% (Q1 2026), 21.54% (Q4 2025) and 49.79% (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,264.65 Bn | 1,238.27 Bn | 20.46 Bn | 33.69% |
| 2 | Johnson & Johnson | 677.74 Bn | 597.60 Bn | 17.30 Bn | 25.03% |
| 3 | AbbVie | 517.10 Bn | 485.11 Bn | 13.12 Bn | 41.97% |
| 4 | Merck | 362.23 Bn | 325.17 Bn | 13.19 Bn | 30.51% |
| 5 | Novartis Ag | 315.90 Bn | 276.16 Bn | 11.24 Bn | 38.60% |
| 6 | Astrazeneca | 289.40 Bn | 266.24 Bn | 12.86 Bn | - |
| 7 | Amgen | 249.90 Bn | 201.56 Bn | 7.58 Bn | 35.25% |
| 8 | Gilead Sciences | 209.15 Bn | 184.26 Bn | 6.73 Bn | 57.81% |
| 9 | Pfizer | 165.88 Bn | 113.23 Bn | 12.56 Bn | 28.96% |
| 10 | Vertex Pharmaceuticals | 138.78 Bn | 110.77 Bn | 2.91 Bn | 15.86% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 38.60% |
| Mar 31, 2026 | 30.67% |
| Dec 31, 2025 | 21.54% |
| Sep 30, 2025 | 49.79% |
| Jun 30, 2025 | 45.06% |
| Mar 31, 2025 | 29.46% |
| Dec 31, 2024 | 36.12% |
| Sep 30, 2024 | 51.52% |
| Jun 30, 2024 | 36.88% |
| Mar 31, 2024 | 21.07% |
| Dec 31, 2023 | 25.85% |
| Sep 30, 2023 | 47.86% |
| Jun 30, 2023 | 29.30% |
| Mar 31, 2023 | 28.94% |
| Dec 31, 2022 | 41.76% |
| Sep 30, 2022 | 47.10% |
| Jun 30, 2022 | 27.37% |
| Mar 31, 2022 | 15.21% |
| Dec 31, 2021 | 32.84% |
| Sep 30, 2021 | 40.49% |
API Access
Novartis Ag FCF Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=fcf-margin&ticker=NVS&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "fcf-margin", "ticker": "NVS", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=fcf-margin&ticker=NVS&period=max&api_key=YOUR_API_KEY");
const data = await res.json();